Knowledge, attitude, and practices regarding proton pump inhibitors among community pharmacists and pharmacy students. 2023

E Hamurtekin, and A S Bosnak, and A Azarbad, and R Moghaddamshahabi, and Y Hamurtekin, and R B Naser
Department of Pharmacology, Faculty of Pharmacy, Eastern Mediterranean University, Famagusta, North Cyprus, Mersin 10, Turkey.

There are concerns about inappropriate use and insufficient knowledge of proton pump inhibitors (PPIs) use among medical staff. This study was designed to examine pharmacy students' and community pharmacists' knowledge, attitude, and practices toward PPIs and their relationship with specific sociodemographic characteristics. This descriptive study was conducted on the pharmacy students (first and last year) at Eastern Mediterranean University and community pharmacists in North Cyprus Data were collected by a validated questionnaire, which assessed knowledge, attitude, and practices regarding PPI use. Students were included without sampling in a volunteer-based manner. Registered community pharmacists were selected randomly. First-year pharmacy students (n = 77) showed significantly lower knowledge levels than last-year students (12.00 vs. 13.65; P < 0.001); however, there was no significant difference between last-year students (n = 111) and community pharmacists (n = 59). First-year pharmacy students were significantly less aware of PPIs' "dosage and administration" than the other two groups. Last-year students and community pharmacists exhibited significantly higher attitude scores regarding PPI use (24.7 and 24.6 vs. 22.7; P < 0.001). Omeprazole was found to be the most preferred PPI among the three studied populations. Community pharmacists used PPIs mainly to treat acid reflux. Gender, nationality, and pharmacy education program type did not influence pharmacy students' knowledge, attitude, or practices. There was not a significant difference regarding knowledge and attitude between the last-year pharmacy students and community pharmacists. The practices of community pharmacists were significantly different from the pharmacy students. It was concluded that certain essential topics regarding PPI use should be emphasized in pharmacy education and during pharmacy practice. Further, it is essentially important for community pharmacists to continue their education through training programs after graduation to enhance their knowledge of PPI use.

UI MeSH Term Description Entries
D007722 Health Knowledge, Attitudes, Practice Knowledge, attitudes, and associated behaviors which pertain to health-related topics such as PATHOLOGIC PROCESSES or diseases, their prevention, and treatment. This term refers to non-health workers and health workers (HEALTH PERSONNEL). Knowledge, Attitudes, Practice
D009853 Omeprazole A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. H 168-68,Omeprazole Magnesium,Omeprazole Sodium,Prilosec,H 168 68,H 16868,Magnesium, Omeprazole,Sodium, Omeprazole
D010595 Pharmacists Those persons legally qualified by education and training to engage in the practice of pharmacy. Clinical Pharmacists,Community Pharmacists,Retail Pharmacists,Clinical Pharmacist,Community Pharmacist,Pharmacist,Pharmacist, Clinical,Pharmacist, Community,Pharmacist, Retail,Pharmacists, Clinical,Pharmacists, Community,Pharmacists, Retail,Retail Pharmacist
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013339 Students, Pharmacy Individuals enrolled in a school of pharmacy or a formal educational program leading to a degree in pharmacy. Pharmacy Student,Pharmacy Students,Student, Pharmacy
D054328 Proton Pump Inhibitors Compounds that inhibit H(+)-K(+)-EXCHANGING ATPASE. They are used as ANTI-ULCER AGENTS and sometimes in place of HISTAMINE H2 ANTAGONISTS for GASTROESOPHAGEAL REFLUX. Proton Pump Inhibitor,Inhibitor, Proton Pump,Inhibitors, Proton Pump,Pump Inhibitor, Proton

Related Publications

E Hamurtekin, and A S Bosnak, and A Azarbad, and R Moghaddamshahabi, and Y Hamurtekin, and R B Naser
February 2019, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society,
E Hamurtekin, and A S Bosnak, and A Azarbad, and R Moghaddamshahabi, and Y Hamurtekin, and R B Naser
July 2022, Primary health care research & development,
E Hamurtekin, and A S Bosnak, and A Azarbad, and R Moghaddamshahabi, and Y Hamurtekin, and R B Naser
July 2018, JPMA. The Journal of the Pakistan Medical Association,
E Hamurtekin, and A S Bosnak, and A Azarbad, and R Moghaddamshahabi, and Y Hamurtekin, and R B Naser
January 2014, Iranian journal of pharmaceutical research : IJPR,
E Hamurtekin, and A S Bosnak, and A Azarbad, and R Moghaddamshahabi, and Y Hamurtekin, and R B Naser
January 2021, PloS one,
E Hamurtekin, and A S Bosnak, and A Azarbad, and R Moghaddamshahabi, and Y Hamurtekin, and R B Naser
December 2019, Acta tropica,
E Hamurtekin, and A S Bosnak, and A Azarbad, and R Moghaddamshahabi, and Y Hamurtekin, and R B Naser
June 2012, Journal of basic and clinical pharmacy,
E Hamurtekin, and A S Bosnak, and A Azarbad, and R Moghaddamshahabi, and Y Hamurtekin, and R B Naser
September 2021, Journal of family medicine and primary care,
E Hamurtekin, and A S Bosnak, and A Azarbad, and R Moghaddamshahabi, and Y Hamurtekin, and R B Naser
August 2019, Cureus,
E Hamurtekin, and A S Bosnak, and A Azarbad, and R Moghaddamshahabi, and Y Hamurtekin, and R B Naser
December 2019, Therapie,
Copied contents to your clipboard!